Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	82.4	21.46	41.01	36.19	60.86
Cash & Short-Term Investments	82.4	21.46	41.01	36.19	60.86
Cash Growth	283.94%	-47.67%	13.31%	-40.52%	139.05%
Other Current Assets	0.7	0.81	0.99	3.97	1.35
Total Current Assets	83.1	22.27	42	40.16	62.2
Net Property, Plant & Equipment	-	0.01	0.01	0.02	-
Other Intangible Assets	-	-	0.02	0.04	0.05
Goodwill	14.87	14.87	14.87	14.87	14.87
Total Assets	97.97	37.14	56.9	55.09	77.12
Accounts Payable	0.64	1.61	1.81	0.97	1.85
Accrued Expenses	1.65	1.23	1.54	0.41	0.97
Total Current Liabilities	2.29	2.84	3.34	1.38	2.82
Long-Term Debt	60	60	82.02	73.73	66.33
Other Long-Term Liabilities	171.46	-	-	-	-
Total Long-Term Liabilities	231.46	60	82.02	73.73	66.33
Total Liabilities	233.76	62.84	85.36	75.11	69.15
Common Stock	0	0	0	0	0
Additional Paid-in Capital	548.05	369.68	368.36	346.79	342.68
Retained Earnings	-688.8	-395.38	-396.82	-366.81	-334.7
Total Common Shareholders' Equity	-140.75	-25.69	-28.46	-20.02	7.98
Minority Interest	4.96	-	-	-	-
Shareholders' Equity	-135.79	-25.69	-28.46	-20.02	7.98
Total Liabilities & Equity	97.97	37.14	56.9	55.09	77.12
Total Debt	60	60	82.02	73.73	66.33
Net Cash (Debt)	22.4	-38.54	-41	-37.54	-5.47
Net Cash Per Share	2.65	-5.09	-6.30	-6.99	-1.02
Book Value	-140.75	-25.69	-28.46	-20.02	7.98
Book Value Per Share	-16.63	-3.39	-4.37	-3.73	1.49
Tangible Book Value	-155.62	-40.56	-43.34	-34.94	-6.94
Tangible Book Value Per Share	-18.39	-5.36	-6.66	-6.51	-1.30

Updated Mar 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q